Nuritas Ltd
10
3
3
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
The Effects of PeptiStrong and Whey on Muscle Function In Older Adults
Role: lead
Effects of PeptiSleep on Sleep Quality in Healthy Adults
Role: lead
The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population
Role: lead
Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance
Role: lead
Effects of PeptiSleep in Healthy Males and Females With Mild to Moderate Sleep Impairment
Role: lead
A Study to Determine the Safety and Tolerability of a Range of Doses of PeptiControl in Pre-diabetic Individuals
Role: lead
The Effects of PeptiStrong and Exercise to Enhance Muscle Strength in Young Subjects
Role: lead
Effects of Protein Hydrolysate Supplementation Influencing Strength Recovery and Expression of Muscle Damage Markers Post-exercise
Role: lead
Effects of Protein Hydrolysate Supplement on Systemic Muscle Function Markers Following Resistance Type Exercise in Male Subjects
Role: lead
Study to Evaluate Bioactive Peptides' Effect on Digestive Discomfort Symptoms of the Elderly
Role: lead
All 10 trials loaded